Scientists have found a chemical in the blood of human beings that indicates that the function of brains has declined. In the earliest signs of Alzheimer, about 1,129 proteins were found circulating in the blood of about 200 twins. This report was compared with the cognitive function test in translational psychiatry. The lowering of presence of one protein, MAPKAPK5 was seen in the people whose brain had declined.
MAPKAPK5 is responsible for relaying the chemical messages that comes within the body and its connection with the cognitive decline was also very unclear. The cases of dementia will spread by 2050 in the world but sadly there is no treatment or cure for this. These changes in brain may also result in loss of memory, confusion and change of personality. Many drug companies also believe that all the patients having these symptoms should be cured immediately and protect any damage to the brains.
The Medical Research Council told that if prevention is not taken, it will be hard to reverse the damages that might have occurred in the brain. If there are symptoms of such diseases, care should be taken so that correct treatment is done. A blood test can help in identifying all the clinical trials. The protein is linked with all the possible changes of memory and thinking. Diagnosis of this disease cannot be called science exactly but steps should be taken for timely and accurate diagnosis. The treatment will fully depend on this.